✦ LIBER ✦
Thirty-month follow-up after intravitreal bevacizumab in progressive idiopathic macular telangiectasia type 2
✍ Scribed by Matt, G; Sacu, S; Ahlers, C; Schütze, C; Dunavoelgyi, R; Prager, F; Pruente, C; Schmidt-Erfurth, U
- Book ID
- 109852545
- Publisher
- Nature Publishing Group
- Year
- 2010
- Tongue
- English
- Weight
- 478 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0950-222X
No coin nor oath required. For personal study only.